Goodwin advised Alnylam Pharmaceuticals, Inc. on its strategic restructuring of its RNAi therapeutics alliance with Sanofi to streamline and optimize development and commercialization of certain products…
Alnylam Pharmaceuticals and Sanofi’s Strategic Restructuring of RNAi Therapeutics Rare Disease Alliance
